Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07394608

Paired Non-invasive VNS in Adolescent Cerebral Palsy Rehabilitation

This is an open-label safety and feasibility trial evaluating the use of paired non-invasive vagus nerve stimulation (VNS) and upper extremity (UE) rehabilitation in the motor impairment reduction of adolescent patients with spastic cerebral palsy.

Recruiting

Interested in participating?

Request Info

Key information

Age range

12 year–17 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

The Charles Lazarus Children's Abilities Center

New York, 10029, United States

Location status: Recruiting

Location contact

David Putrino

PRINCIPAL_INVESTIGATOR

Jenna Tosto Mancuso, PT, DPT,NCS

CONTACT

[email protected]

212-241-8454

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age 12-17 years old
  • Diagnosis of spastic cerebral palsy
  • Gross Motor Function Classification System (GMFCS) Level II-III (will be evaluated at screening)
  • Jebsen Taylor Hand Function Test Score of <37.08 on the affected side at time of screening visit (will be evaluated at screening)
  • Ability to communicate and follow two step commands at the time of screening
  • Ability to provide assent as detailed in consent form and based on assessment using the University of California, San Diego Brief Assessment of Capacity to Consent

Exclusion criteria

  • Previous vagus nerve injury
  • Less than 12 years old or greater than 18 years old
  • History of left or bilateral vagotomy
  • Current use of other implanted stimulation devices including but not limited to pacemaker, deep brain stimulator, implanted vagus nerve stimulators, cochlear implants, implantable cardiac defibrillators (ICDs)etc.
  • Current use of any investigational devices or investigational drugs not otherwise specified - Past Medical History for any of the following:
  • Acute suicidal thinking or behavior
  • History of schizophrenia, schizoaffective disorder, or delusional disorders
  • History of rapid cycling bipolar disorder
  • Progressive neurological diseases
  • Cardiac arrhythmias or other abnormalities
  • History of dysautonomia including but not limited to orthostatic hypotension, postural orthostatic tachycardia syndrome, vasovagal syncope etc.
  • GMFCS score of less than II or greater than III (will be evaluated at screening)
  • Jebsen Taylor Hand Function Test Score of >37.08 on the affected side at time of screening visit (will be evaluated at screening)

Treatment and study plan

Non-invasive taVNS

Device

Device activates the vagus through the ear. The device is controlled via the Vagustim mobile app, which connects using Bluetooth Low Energy (BLE).

Other names: Non-invasive, transauricular, vagus nerve stimulation device, Vagustim

Primary outcomes

  1. Number of adverse event and serious adverse events

    Time frame: 12 months

    Safety is assessed by adverse event.

Secondary outcomes

  1. Number of therapy sessions complete

    Time frame: end of therapy visits at Day 46

    Number of therapy sessions complete

  2. Active training time per session

    Time frame: end of therapy visits at Day 46

    Number of minutes of training per session

  3. Number of movement repetitions completed per session

    Time frame: end of therapy visits at Day 46

    Number of movement repetitions completed per session.

  4. Jebsen Taylor Hand Function Test (JTHFT)

    Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months

    The Jebsen Taylor Hand Function Test (JTHFT) is a standardized and objective measure of fine and gross motor hand functions that uses simulated activities of daily living (ADLs) assessed by time to completion; typically up to several minutes depending on impairment

  5. BOT-2

    Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months

    The BOT-2 is a standardized assessment of motor proficiency in children and adolescents. It evaluates fine motor skills, manual dexterity, coordination, and motor integration through structured performance tasks.

    Fine Motor Precision (Upper Extremity) scored 0-41, higher score indicates better precision Fine Motor Integration (Upper Extremity) scored 0-45, higher score indicates better integration Manual Dexterity (Upper Extremity) scored 0- 45, higher score indicates better manual dexterity.

    Upper-Limb Coordination scored 0-30, higher score indicates better upper-limb coordination.

  6. ABILHANDS

    Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months

    ABILHAND is a patient-reported outcome measure that evaluates a person's perceived manual ability to perform daily bimanual activities. It assesses how difficult activities are to perform using both hands.

    The ABILHAND-Kids logit score ranges from -6 logits to +6 logits, higher score indicates better bimanual manual ability (tasks are perceived as easier).

  7. Pediatric Evaluation of Disability (PEDI)

    Time frame: at 12 months

    The PEDI assesses functional abilities and performance in children across three domains: self-care, mobility, and social function. It measures both capability and caregiver assistance.

    Subscale range and full range uses scaled scores standardized to a 0-100 metric. Higher scores indicate better functional abilities and greater independence.

  8. Pediatric Quality of Life Inventory (PedsQL)

    Time frame: baseline Day 1, start of therapy Day 3, end of therapy Day 46, and 3, 6, 9, and 12 months

    The PedsQL is a standardized patient-reported outcome measure assessing health-related quality of life in children across domains including physical, emotional, social, and school functioning.

    Subscales range and full scale scores are transformed to a 0-100 scale. Higher scores indicate better health-related quality of life.

Study contacts

Contact information is provided by the study sponsor or research team.

Jenna Tosto Mancuso, PT, DPT,NCS

CONTACT

[email protected]

212-241-8454

Sponsors and collaborators

Lead sponsor

Icahn School of Medicine at Mount Sinai

Other

Registry information

Official study title

Use of Paired Non-Invasive Vagus Nerve Stimulation in Rehabilitation of Adolescents With Cerebral Palsy: An Open Label Safety Feasibility Trial

Important dates

Study start
2026
Primary completion
2028
Study completion
2028
First posted
Feb 6, 2026
Registry last updated
Mar 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.